We evaluated three actions of 1,25-dihydroxycholecalciferol 11,25-(OH)2D31 in human skin fibroblasts to test for heterogeneity in hormone-response coupling. In fibroblasts from normal subjects the 1,25-OH)2D3 concentrations for half-maximal effect (EC50) were: for mitogenic effect 0.0001-0.0005 nM, for antimitogenic effect 1 nM, and for induction of 25-OHD3 24-hydroxylase (24-OHase) 5 nM. To evaluate the effects of mutations presumed to be in the gene for the 1,25-(OH)2D3 receptor we examined cell lines representing four kindreds with hereditary resistance to 1,25-(OH)2D3 ("mutant" cell lines). In one mutant cell line all three 1,25-(OH)2D3 actions were severely abnormal. In one mutant cell line 24-OHase induction and mitogenic action were undetectable, but EC50 and maximal effect were normal for antimitogenic action of 1,25-(OH1)D3. In two mutant cell lines 24-OHase induction and antimitogenic actions were undetectable or severely impaired but mitogenic action was normal in EC50 and normal or increased in maximal effect. The mitogenic and antimitogenic actions in normal cells showed a similar profile of potency ratios for 1,25-(OH)2D3 and six analogues. Whenever a mutant cell showed a normal or even an abnormal mitogenic or antimitogenic effect of 1,254-OH)2D3, these effects showed potency ratios similar to wild type, suggesting mediation by a similar 1,2540H)2D3 receptor.
Introduction
It has been generally believed that the induction mechanism of all 1,25-dihydroxyvitamin D3 (1,25-(OH)2D3)' receptor actions is the same, and that a defect in one 1,25-(OH)2D3 receptor action implies similar defects in all 1,25-(OH)2D3 receptor actions. However, certain actions of 1,25-(OH)2D3 in a tive results. Cells were incubated in serum-free medium for 24 h before experiments. Induction of24-OHase. All 24-OHase assays on normal or mutant cells were done as previously described (8) , with minor modifications. These modifications include increase in cell number/tube (3 million/ tube), and filtration of extracts prior to chromatography on a microfilter (Millipore HV 0.45 um; Nichon Millipore, Kogyo, Japan) to prevent loss of materials on the guard column. The three mutant cell lines that had been tested previously (8, 10) were reanalyzed in one experiment. The fourth mutant cell line (12) and the normals were analyzed in two separate experiments in triplicate. All 24-vial plates (Costar) . Experimental conditions were then optimized for testing either antimitogenic effect (A) or mitogenic effect (B) of calciferols. Each cell line was tested with both protocols at least four times.
For protocol A cells were used within 1 d after reaching confluency. They were placed into serum-free media for 24 h; then different concentrations of 1,25-(OH)2D3 or 1,25-OH)2D3 analogue were added in serum-free medium for another 24 h.
For protocol B cells were used at half confluency and also maintained in serum-free medium for 24 h before testing; then 1,25-OH)2D3 analogues were added in a medium supplemented with 0.2 ,AM insulin and with 10% calciferol-free bovine serum for another 24 h.
After 24 h the media were replaced with fresh aliquots ofthe same media (without or with calciferols) with [3H]thymidine at a final concentration of 1 uCi/ml, for another 24 h. The reaction was stopped with removal of medium, and cell monolayers were washed with icecold PBS containing 2 mM thymidine. Cell associated acid insoluble materials were precipitated by addition of 500 Mul 5% trichloroacetic acid solution to the monolayers and incubation for 2 h at 4VC. Then the dried precipitate was solubilized with 1 N sodium chloride. Radioactivity was counted in a liquid scintillation counter, and data were expressed as percentage of counts in control wells without hormone added (mean±l SE). Control values for different experiments were 5,700±300 counts/min n = 504 for protocol A, and 3,000±200 cpm n = 336 for protocol B. Normal cells and mutant cells always were included in the same assay, and their control values did not differ significantly.
Measurement of DNA content with microfluorimetry. Effects of 1,2540H)2D3 analogues on cell growth were monitored by serial measurement of DNA content with a rapid staining technique (13 (Fig. 2, left ) the maximal inhibitory effect reached 18±4% of control, with an EC50 at 1 nM 1,25-OH)2D3. In the presence of serum (Fig. 2, right ) the maximal inhibitory effect was similar (21±3), but the ECs0 was at 10-fold higher 1,25-(OH)2D3 concentration (10 nM).
Using microfluorimetry we also found an inhibitory effect of 1,25-(OH)2D3 on cell growth (Fig. 3, left) . This effect of Using microfluorometric measurement of DNA content, we were also unable to detect a mitogenic action of 1,25-(OH)2D3 in the absence of serum and insulin. In the presence of serum and insulin, however, mitogenic action occurred after 24 h incubation with hormone ( Fig (Table I) . Antimitogenic effect of 1,25-(OH)2D3. Under serum-free conditions (Fig. 4 , left) the maximal inhibitory effect (16±4%) of 10-6 M 1,25-(OH)2D3 was within the normal range, but EC50 (10 nM) was 10-fold greater than normal. In the presence of serum (Fig. 4 , right) the maximal inhibitory effect (63±4% of baseline) was less (P < 0.001) than in normal cells (21±4%), and the EC50 for 1,25-(OH)2D3 (100 nM) was 100-fold greater than normal.
Using microfluorometric detection of DNA content, maximal inhibitory action of was within the normal range, reaching maximum on the 6th day (17±8% of control), and EC50 was increased 10-fold to 10 nM. In the presence of serum the inhibitory action was less (maximum inhibition 68%±5% ofcontrol on the 7th day) than in normal cells (P < 0.05), and EC50 was 100 nM.
Mitogenic effect of1,25-(OH)2D3. The stimulatory effect of 1,25-(OH)2D3 on [3H]thymidine incorporation was detectable in serum-supplemented media (maximum 128±6%, and EC50 100-fold greater than normal) (Fig. 4, right) . The (Fig. 6, left) . (Fig. 6, right). The maximal stimulatory effect (245±9%) at 10-" M 1,25-(OH)2D3 was greater than the normal maximal stimulatory effect (P < 0.001) in nine experiments.
Microfluorometric measurement of DNA content revealed similarly accentuated stimulatory effect reaching a maximum (444±6%) after 48 h hormone exposure at 10-12 M 1,2540H)2D3, in the presence of serum (Fig. 3) . 24 -OHase was induced to a normal maximal activity (7) (Fig. 1) .
Antimitogenic effect of 1,25-(OH)2D3. In cell line 2 inhibitory effect of 1,25-(OH)2D3 on DNA synthesis was highly abnormal. In the presence of serum (Fig. 7, right) we could not detect inhibition of [3H]thymidine incorporation at any l,25-(OH)2D3 dose. In the absence of serum (Fig. 7, left) maximum (185+7%; P < 0.01 compared to normal maximum) at 10-10 M 1,25-(OH)2D3 (Fig. 7, right) .
Using microfluorimetry we found a time-dependent increase in mitogenic effect with a maximum of 300% increase on the 5th day at 10-12 M 1,25-(OH)2D3, in the presence of serum (Fig. 3) Table III ).
Responses that were defective (in 1,25-(OH)2D3 maximal effect or EC50) but measurable in mutant cells also showed normal analogue potency ratios (mutant cell lines 2 and 10 in Table IV or line 10 in Table V compared and insulin (presumably IGF-l/somatomedin-C since insulin acts on the latter's receptor at the high concentrations we employed [14] ). Prior reports have also suggested that the mitogenic action of 1,25-(OH)2D3 may involve serum or growth factors (15) , such as PDGF (15) , interleukins (16), or epidermal growth factor (16). We also found that confluency status had to be optimized, supporting prior studies on the importance of confluency (17) or differentiation (18) .
We observed biphasic effects of i,25-(OH)2D3 on growth of normal skin fibroblasts, using a short-term assay based on [3H]thymidine incorporation or using a long-term assay based on total DNA content. Biphasic 1,25-(OH)2D3 effects with stimulation of DNA synthesis at low doses and inhibition at higher doses have been observed previously in normal or malignant cells (19) (20) (21) .
Antimitogenic effects of 1,25-(OH)2D3 on DNA synthesis have been observed in many cell systems, often accompanied by induction of cell differentiation (20, 22) .
Mitogenic effects of 1,25-(OH)2D3 on DNA synthesis have been described in embryonic fibroblasts (22) , in cartilage (17), in T lymphocytes (23) , and in monocytes (24) . While mitogenic effects of 1,25-(OH)2D3 have been found in only few systems and have been of modest magnitude, the strikingly lower ECQ0 for mitogenic than for antimitogenic effect in our studies and in prior studies (19) (20) (21) (22) suggests that the mitogenic effect is physiologically important.
In mutant cell lines 2 and 7 with the most severe deficiency of antimitogenic effect, we noted an exaggerated amplitude of the mitogenic effect. Apparently the biphasic 1,25-(OH)2D3 dose-response relations result from interactions of two opposing effects; loss of one 1,25-(OH)2D3 effect (by selective assay conditions or by receptor mutation) allows the opposing one to be seen more clearly. The exaggerated mitogenic effects of 1,25-(OH)2D3 in cell lines 2 and 7 showed time courses different from normal and from each other (Fig. 3, right) ; the determinants of these time courses are not known. (25) , but the molecular basis for this form of heterogeneity in action of 1,25-(OH)2D3 or other steroids has not been determined.
The absolute value of an EC50, per se, must be interpreted with caution; we and others (24) noted a 10-fold difference in the EC50 for antimitogenic action of 1,25-(OH)2D3 depending on serum addition, and EC50 for mitogenic actions were gener- (5) . The amino terminus of the progesterone receptor has been shown to help select the target gene, and a synthetic receptor construct was shown to retain selectively one but not another effect (33) . Some steroid receptor target genes have variable numbers of receptor recognition elements, thereby presenting opportunities for varying cooperative effects in receptor actions (2, 4, 6) . Heterogeneous coupling mechanisms are also possible through receptor interactions with an increasing spectrum of transcription factors (34, 35) . For example, in certain target genes, no receptor recognition element may be present, and the receptor may modulate the gene by interacting with another DNA-binding protein (5, 36) . In addition to transcriptional actions, posttranscriptional effects have been suggested for 1,25-(OH)2D3 (37), and other steroids (7, 38) .
While we do not know if our molecular classification of receptor defects will predict similar patterns of response retention in other mutant cell lines, we present below several speculations to illustrate how the observed response patterns might arise. (5, 36) . In fact, the retained mitogenic effect in mutant lines 2 and 7 with defective nuclear interactions of receptor suggests this effect could be at a cytoplasmic target of the receptor.
We have shown that i,25-(OH)2D3 coupling to three different actions differs strikingly in EC50 and in dependency on receptor functions that are compromised by certain mutations. This heterogeneity implies that full information on the normal mechanism of 1,25-(OH)2D3 receptor actions will require detailed studies of multiple responses. 1,25-(OH)2D3 effects on DNA synthesis seem to provide indices for two distinct receptor functions, while induction of 24-hydroxylase activity measures a third that correlates best of these three with the calcemic effect3 of 1,25-(OH)2D3.
